Cell-Free DNA Modification Dynamics in Abiraterone Acetate-Treated Prostate Cancer Patients

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Clinical Cancer Research

• Publication date

  2018-04-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-18-0101PMID 29615462
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA hypomethylation of CBS promoter induced by folate deficiency is a potential noninvasive circulating biomarker for colorectal adenocarcinomas.

  2017cited by this paper
• Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer

  2017cited by this paper
• Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patients

  2017cited by this paper
• Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer

  2017cited by this paper
• Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles

  2016cited by this paper
• Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies

  2016cited by this paper
• Quantitative comparison of DNA methylation assays for biomarker development and clinical applications

  2016cited by this paper
• Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer

  2016cited by this paper
• DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer

  2016cited by this paper
• CYP17 inhibitors in prostate cancer: latest evidence and clinical potential

  2016cited by this paper
• Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA

  2016cited by this paper
• Abiraterone in the management of castration-resistant prostate cancer prior to chemotherapy

  2015cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• Fitting Linear Mixed-Effects Models Using lme4

  2014cited by this paper
• InterProScan 5: genome-scale protein function classification

  2014cited by this paper
• HOX genes and their role in the development of human cancers

  2014cited by this paper
• DiffVar: a new method for detecting differential variability with application to methylation in cancer and aging

  2014cited by this paper
• The Dynamics of DNA Methylation Covariation Patterns in Carcinogenesis

  2014cited by this paper
• Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays

  2014cited by this paper
• Abiraterone for treatment of metastatic castration-resistant prostate cancer: a systematic review and meta-analysis.

  2014cited by this paper
• Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate Cancer

  2014cited by this paper
• DNA methylation arrays as surrogate measures of cell mixture distribution

  2012cited by this paper
• Complete pipeline for Infinium(®) Human Methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation.

  2012cited by this paper
• Abiraterone and increased survival in metastatic prostate cancer.

  2011cited by this paper
• Increased methylation variation in epigenetic domains across cancer types

  2011cited by this paper
• Cell-free nucleic acids as biomarkers in cancer patients

  2011cited by this paper
• ZMIZ1 Preferably Enhances the Transcriptional Activity of Androgen Receptor with Short Polyglutamine Tract

  2011cited by this paper
• Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth.

  2010cited by this paper
• Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis

  2010cited by this paper
• Involvement of members of the cadherin superfamily in cancer.

  2009cited by this paper
• Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells.

  2008cited by this paper
• Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

  2008cited by this paper
• Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

  2008influential reference
• Loss of HOXC6 expression induces apoptosis in prostate cancer cells

  2005cited by this paper
• Aberrant HOXC expression accompanies the malignant phenotype in human prostate.

  2003cited by this paper
• Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation *

  2002cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper

• Protocol for non-invasive tumor monitoring and diagnosis based on interpretable deep learning

  2026cites this paper
• Gene-body DNA methylation of ONECUT2 predicts its expression and prostate cancer aggressiveness in needle biopsies

  2026cites this paper
• DNA methylation heterogeneity in complex tumor microenvironment: Quantitative methods, influencing factors, and clinical implications

  2025cites this paper
• Efficient and accurate non-invasive tumor monitoring and diagnosis by interpretable deep learning

  2025cites this paper
• Cell-free DNA methylation and its potential as a biomarker in liquid biopsy: A systematic review.

  2025cites this paper
• The Years 2015–2025 as a Prospective Decade for the Identification of Specific Methylation Biomarkers of Prostate Cancer

  2025cites this paper
• DNA methylation alterations in prostate cancer: from diagnosis to treatment

  2025cites this paper
• Circulating tumor DNA methylation: a promising clinical tool for cancer diagnosis and management

  2024cites this paper
• Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review

  2024cites this paper
• Enhancing clinical potential of liquid biopsy through a multi-omic approach: A systematic review

  2023cites this paper
• Liquid biopsies for cancer: From bench to clinic

  2023cites this paper
• HiTAIC: hierarchical tumor artificial intelligence classifier traces tissue of origin and tumor type in primary and metastasized tumors using DNA methylation

  2023cites this paper
• MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples

  2023cites this paper
• A novel methylated cell-free DNA marker panel to monitor treatment response in metastatic prostate cancer.

  2022cites this paper
• The Potential of Circulating Cell-Free DNA Methylation as an Epilepsy Biomarker

  2022cites this paper
• Future directions for precision oncology in prostate cancer

  2022cites this paper
• From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer

  2022cites this paper
• Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges

  2022cites this paper
• Targeting signaling pathways in prostate cancer: mechanisms and clinical trials

  2022cites this paper
• Circulating cell-free DNA methylation mirrors alterations in cerebral patterns in epilepsy

  2022cites this paper
• Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer

  2022cites this paper
• Tumor fractions deciphered from circulating cell-free DNA methylation for cancer early diagnosis

  2022cites this paper
• Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate Cancer.

  2021cites this paper
• Plasma Cell-Free DNA Methylomics of Bipolar Disorder With and Without Rapid Cycling

  2021cites this paper
• Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer

  2021cites this paper
• The Epigenetic Factors that Drive Cancer Drug Resistance.

  2021cites this paper
• Detection and relevance of epigenetic markers on ctDNA: recent advances and future outlook

  2021cites this paper
• Epigenetics in prostate cancer: clinical implications

  2021cites this paper
• Evaluating liquid biopsies for methylomic profiling of prostate cancer

  2020cites this paper
• Liquid biopsy in lymphoma: Molecular methods and clinical applications.

  2020cites this paper
• Dynamics of the cell-free DNA methylome of metastatic prostate cancer during androgen-targeting treatment.

  2020cites this paper
• Dynamics of the cell-free DNA methylome of metastatic prostate cancer during androgen-targeting treatment

  2020cites this paper
• Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.

  2020cites this paper
• Cell-Free DNA-Methylation-Based Methods and Applications in Oncology

  2020influential citation
• Extracellular genetic materials and their application in clinical practice.

  2020cites this paper
• Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy

  2019cites this paper
• Epigenomic technologies for deciphering circulating tumor DNA.

  2019cites this paper
• Interaction of an abiraterone with calf thymus DNA: Investigation with spectroscopic technique and modeling studies

  2019cites this paper
• Diagnostic Value of Concentration of Circulating Cell-Free DNA in Breast Cancer: A Meta-Analysis

  2019cites this paper
• The Translational Status of Cancer Liquid Biopsies

  2019cites this paper
• Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy

  2019cites this paper
• Annual Report 2018

  2018cites this paper
• Tumor fraction in cell-free DNA as a biomarker in prostate cancer.

  2018cites this paper
• Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease

  2018cites this paper